Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity.

Talley NJ, Holtmann GJ, Jones M, Koloski NA, Walker MM, Burns G, Potter MDE, Shah A, Keely S.

Gut. 2019 Sep 28. pii: gutjnl-2019-318664. doi: 10.1136/gutjnl-2019-318664. [Epub ahead of print] No abstract available.

PMID:
31563879
2.

Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome.

Talley NJ, Holtmann G, Walker MM, Burns G, Potter M, Shah A, Jones M, Koloski NA, Keely S.

Clin Transl Gastroenterol. 2019 Jul;10(7):e00064. doi: 10.14309/ctg.0000000000000064.

3.

Letter: gluten sensitivity in patients with inflammatory bowel disease.

Potter MD, Walker MM, Jones MP, Koloski NA, Keely S, Talley NJ.

Aliment Pharmacol Ther. 2018 Nov;48(10):1167-1168. doi: 10.1111/apt.15012. No abstract available.

PMID:
30375691
4.

Wheat Intolerance and Chronic Gastrointestinal Symptoms in an Australian Population-based Study: Association Between Wheat Sensitivity, Celiac Disease and Functional Gastrointestinal Disorders.

Potter MDE, Walker MM, Jones MP, Koloski NA, Keely S, Talley NJ.

Am J Gastroenterol. 2018 Jul;113(7):1036-1044. doi: 10.1038/s41395-018-0095-7. Epub 2018 Jun 19.

PMID:
29915405
5.

Erratum to: The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting.

Koloski NA, Jones M, Hammer J, von Wulffen M, Shah A, Hoelz H, Kutyla M, Burger D, Martin N, Gurusamy SR, Talley NJ, Holtmann G.

Dig Dis Sci. 2017 Sep;62(9):2607. doi: 10.1007/s10620-017-4674-z. No abstract available.

PMID:
28689252
6.

The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting.

Koloski NA, Jones M, Hammer J, von Wulffen M, Shah A, Hoelz H, Kutyla M, Burger D, Martin N, Gurusamy SR, Talley NJ, Holtmann G.

Dig Dis Sci. 2017 Aug;62(8):1913-1922. doi: 10.1007/s10620-017-4599-6. Epub 2017 May 27. Erratum in: Dig Dis Sci. 2017 Jul 8;:.

PMID:
28551709
7.

Mood and Anxiety Disorders Precede Development of Functional Gastrointestinal Disorders in Patients but Not in the Population.

Jones MP, Tack J, Van Oudenhove L, Walker MM, Holtmann G, Koloski NA, Talley NJ.

Clin Gastroenterol Hepatol. 2017 Jul;15(7):1014-1020.e4. doi: 10.1016/j.cgh.2016.12.032. Epub 2017 Jan 10.

PMID:
28087404
8.
9.

Dyspepsia and the microbiome: time to focus on the small intestine.

Zhong L, Shanahan ER, Raj A, Koloski NA, Fletcher L, Morrison M, Walker MM, Talley NJ, Holtmann G.

Gut. 2017 Jun;66(6):1168-1169. doi: 10.1136/gutjnl-2016-312574. Epub 2016 Aug 3. No abstract available.

PMID:
27489239
10.

Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study.

Koloski NA, Jones M, Talley NJ.

Aliment Pharmacol Ther. 2016 Sep;44(6):592-600. doi: 10.1111/apt.13738. Epub 2016 Jul 22.

11.

Identification of early environmental risk factors for irritable bowel syndrome and dyspepsia.

Koloski NA, Jones M, Weltman M, Kalantar J, Bone C, Gowryshankar A, Walker MM, Talley NJ.

Neurogastroenterol Motil. 2015 Sep;27(9):1317-25. doi: 10.1111/nmo.12626. Epub 2015 Jul 22.

PMID:
26202154
12.

Editorial: differentiating chronic idiopathic constipation from constipation-predominant irritable bowel syndrome--possible and important?--Authors' reply.

Talley NJ, Koloski NA, Jones MP.

Aliment Pharmacol Ther. 2015 Jun;41(12):1300. doi: 10.1111/apt.13219. No abstract available.

13.

Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study.

Koloski NA, Jones M, Young M, Talley NJ.

Aliment Pharmacol Ther. 2015 May;41(9):856-66. doi: 10.1111/apt.13149. Epub 2015 Mar 4.

14.

Pathways in gut-brain communication: evidence for distinct gut-to-brain and brain-to-gut syndromes.

Keightley PC, Koloski NA, Talley NJ.

Aust N Z J Psychiatry. 2015 Mar;49(3):207-14. doi: 10.1177/0004867415569801. Review.

PMID:
25710826
15.

Predictors of response rates to a long term follow-up mail out survey.

Koloski NA, Jones M, Eslick G, Talley NJ.

PLoS One. 2013 Nov 4;8(11):e79179. doi: 10.1371/journal.pone.0079179. eCollection 2013.

16.

Prevalence correlates and impact of fecal incontinence among older women.

Halland M, Koloski NA, Jones M, Byles J, Chiarelli P, Forder P, Talley NJ.

Dis Colon Rectum. 2013 Sep;56(9):1080-6. doi: 10.1097/DCR.0b013e31829203a9.

PMID:
23929018
17.

Impact of persistent constipation on health-related quality of life and mortality in older community-dwelling women.

Koloski NA, Jones M, Wai R, Gill RS, Byles J, Talley NJ.

Am J Gastroenterol. 2013 Jul;108(7):1152-8. doi: 10.1038/ajg.2013.137. Epub 2013 May 14.

PMID:
23670115
18.

Investigating the directionality of the brain–gut mechanism in functional gastrointestinal disorders.

Koloski NA, Jones M, Talley NJ.

Gut. 2012 Dec;61(12):1776-7. No abstract available.

PMID:
23293789
19.

Psychological impact and risk factors associated with new onset fecal incontinence.

Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ.

J Psychosom Res. 2012 Dec;73(6):464-8. doi: 10.1016/j.jpsychores.2012.07.013. Epub 2012 Aug 19.

PMID:
23148816
20.

Commentary: Psychological disorders linked to functional dyspepsia.

Koloski NA, Jones M, Talley NJ.

Aliment Pharmacol Ther. 2012 Dec;36(11-12):1099-100; discussion 1100-1. doi: 10.1111/apt.12079. No abstract available.

21.

The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study.

Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ.

Gut. 2012 Sep;61(9):1284-90. doi: 10.1136/gutjnl-2011-300474. Epub 2012 Jan 10.

PMID:
22234979
22.

Sexual, physical, verbal/emotional abuse and unexplained chest pain.

Eslick GD, Koloski NA, Talley NJ.

Child Abuse Negl. 2011 Aug;35(8):601-5. doi: 10.1016/j.chiabu.2011.04.007.

PMID:
21862127
23.

What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome? Are current IBS symptom thresholds clinically meaningful?

Koloski NA, Boyce PM, Jones MP, Talley NJ.

Qual Life Res. 2012 Jun;21(5):829-36. doi: 10.1007/s11136-011-9985-5. Epub 2011 Aug 11.

PMID:
21833813
24.

Performance of the Goldberg Anxiety and Depression Scale in older women.

Koloski NA, Smith N, Pachana NA, Dobson A.

Age Ageing. 2008 Jul;37(4):464-7. doi: 10.1093/ageing/afn091. Epub 2008 May 5. No abstract available.

PMID:
18460498
25.

Animal farm: do our four-legged friends hold the answer to inflammatory bowel disease?

Koloski NA, Brett L.

Inflamm Bowel Dis. 2008 Aug;14(8):1163-4. doi: 10.1002/ibd.20454. No abstract available.

PMID:
18348288
26.

Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature.

Koloski NA, Bret L, Radford-Smith G.

World J Gastroenterol. 2008 Jan 14;14(2):165-73. Review.

27.

Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study.

Koloski NA, Boyce PM, Talley NJ.

Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1101-9.

PMID:
16957517
28.
29.
30.
31.

A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome.

Boyce PM, Talley NJ, Balaam B, Koloski NA, Truman G.

Am J Gastroenterol. 2003 Oct;98(10):2209-18.

PMID:
14572570
32.
33.

Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia.

Koloski NA, Talley NJ, Huskic SS, Boyce PM.

Aliment Pharmacol Ther. 2003 Mar 15;17(6):841-51.

34.

Epidemiology and health care seeking in the functional GI disorders: a population-based study.

Koloski NA, Talley NJ, Boyce PM.

Am J Gastroenterol. 2002 Sep;97(9):2290-9.

PMID:
12358247
35.
36.

Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?

Boyce PM, Koloski NA, Talley NJ.

Am J Gastroenterol. 2000 Nov;95(11):3176-83. Erratum in: Am J Gastroenterol 2001 Apr;96(4):1319.

PMID:
11095338
37.

The impact of functional gastrointestinal disorders on quality of life.

Koloski NA, Talley NJ, Boyce PM.

Am J Gastroenterol. 2000 Jan;95(1):67-71.

PMID:
10638561

Supplemental Content

Loading ...
Support Center